Medicinal – Page 103

The 2024 International Society for Human and Animal Mycology (ISHAM)-ABPA working group guidelines: Transforming diagnosis and management of ABPA

mycolabadmin

ABPA is a serious lung disease that develops when the body overreacts to a common fungus called Aspergillus. New international guidelines help doctors better diagnose and treat this condition, which affects many people with asthma and cystic fibrosis. The guidelines make diagnosis easier by using simpler tests and lowering the thresholds for detecting the disease, and they provide clear treatment plans depending on how severe each patient’s disease is. These updated standards are especially important in countries like India where ABPA is very common.

Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration

mycolabadmin

Researchers discovered that a specific protein called GAP-43 plays a crucial role in protecting brain cells from damage caused by α-synuclein, a protein involved in Parkinson’s Disease. When GAP-43 is modified through a process called phosphorylation at certain sites, it promotes the growth of neurites (neural connections) and formation of healthy synapses. The drug FK506, already approved by the FDA, appears to work by controlling this phosphorylation process, offering potential therapeutic benefits for Parkinson’s patients.

Invasive fungal otitis media with peripheral facial paralysis

mycolabadmin

This case describes a rare fungal ear infection caused by Aspergillus fumigatus that spread to the mastoid bone and caused facial nerve paralysis. The patient had ear drainage and hearing loss for 4 years before diagnosis. Treatment required two surgical procedures to remove infected tissue combined with 6 months of antifungal medication, eventually resulting in healing and recovery of facial nerve function.

Mycobiome analyses of critically ill COVID-19 patients

mycolabadmin

This study examined fungal infections in severely ill COVID-19 patients treated in intensive care units across Europe. Researchers found that a dangerous mold called Aspergillus fumigatus was more common in patients who died and less common in those treated with azole antifungal drugs. The findings suggest that giving antifungal medications to critically ill COVID-19 patients when they arrive at the hospital might help prevent fungal-related deaths.

Novel chia (Salvia Hispanica L.) residue-based substrate formulations for oyster mushroom (Pleurotus ostreatus) cultivation

mycolabadmin

Researchers discovered that leftover plant material from chia seed production can be used to grow oyster mushrooms with excellent nutritional value. When chia residues were combined with rice straw in the right proportions, they produced mushrooms with higher protein content, more beneficial compounds, and better yields than traditional growing methods. This finding helps solve two problems at once: it creates a valuable use for chia farming waste while producing highly nutritious mushrooms for human consumption.

Aspergillus terreus IFM 65899-THP-1 cells interaction triggers production of the natural product butyrolactone Ia, an immune suppressive compound

mycolabadmin

Scientists discovered that when a dangerous fungus called Aspergillus terreus is grown together with immune cells, it produces a special compound called butyrolactone Ia that helps it hide from the body’s defense system. This compound works by reducing inflammatory signals that immune cells use to fight the fungus. The research shows that direct contact between the fungus and immune cells is needed to trigger this protective compound production, suggesting the fungus responds directly to the threat of immune attack.

Neuronal TIMP2 regulates hippocampus-dependent plasticity and extracellular matrix complexity

mycolabadmin

Scientists discovered that a protein called TIMP2, which is naturally higher in young blood, plays a crucial role in maintaining brain memory and learning ability. Using laboratory mice, they found that TIMP2 helps keep the brain’s cellular environment flexible by controlling the buildup of structural proteins around nerve connections. Without adequate TIMP2, the brain develops more rigid connections that interfere with forming new memories and creating new brain cells, mimicking changes seen in aging and cognitive decline.

Antifungal effects of metabolites from Arthrinium sp. 2–65 and identification of main active ingredients

mycolabadmin

Scientists discovered that a fungus called Arthrinium sp. 2–65, found living inside a wild plant called Thymus mongolicus, produces two special compounds that can kill the fungus responsible for grey mould disease. Grey mould is a major problem for farmers worldwide, damaging crops like tomatoes, grapes, and strawberries. These newly identified compounds were tested and showed excellent effectiveness against the disease, offering a promising natural alternative to chemical pesticides that have become less effective due to resistance and environmental concerns.

Temporal and thermal optimization of trypsin digestion for the cryptococcal proteome

mycolabadmin

Scientists optimized the process for breaking down fungal proteins from Cryptococcus neoformans, a dangerous fungus that infects humans. By testing different digestion times and temperatures, they found that shortening the process from overnight to just 1 hour still yielded excellent results. This discovery helps researchers study this pathogen more efficiently and could lead to better treatments for cryptococcal infections.

Activation of Secondary Metabolism and Protease Activity Mechanisms in the Black Koji Mold Aspergillus luchuensis through Coculture with Animal Cells

mycolabadmin

Researchers found that growing koji mold (Aspergillus luchuensis) alongside mouse immune cells in the laboratory significantly increases the production of valuable bioactive compounds. The mold releases enzymes called proteases that break down proteins from the animal cells, which the fungus then uses as building blocks to create medicinal compounds. This discovery shows that coculturing microorganisms with animal cells is an effective strategy to unlock hidden chemical production capabilities in fungi, which could lead to new medicines and useful compounds.

Research Topic: Medicinal